CLINICAL_TRIALS
trial_result
· 2017-02-17
Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Meningioma [Phase 2]
Summary
A Phase 2 trial evaluating antineoplaston therapy for meningioma was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Burzynski Research Institute | Conditions: Meningioma | Phase 2 | Status: TERMINATED | Results posted: 2017-02-17